Salvage therapy for refractory or relapsed acute lymphocytic leukemia. [electronic resource]
Producer: 20010628Description: 163-205 p. digitalISSN:- 0889-8588
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- antagonists & inhibitors
- Adult
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis -- drug effects
- Bone Marrow Transplantation
- Cancer Care Facilities -- statistics & numerical data
- Child
- Chromosome Aberrations
- Clinical Trials as Topic
- Combined Modality Therapy
- DNA Methylation -- drug effects
- Disease-Free Survival
- Drug Resistance, Neoplasm
- Enzyme Inhibitors -- therapeutic use
- Humans
- Immunophenotyping
- Multicenter Studies as Topic
- Neoplasm Proteins -- antagonists & inhibitors
- Oligonucleotides, Antisense -- therapeutic use
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Recurrence
- Remission Induction
- Risk Factors
- Salvage Therapy
- Survival Analysis
- Texas -- epidemiology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.